Skip to main content
TNYA
NASDAQ Life Sciences

Tenaya Therapeutics Narrows Q1 Net Loss to $19.3M, Advances Clinical Pipeline

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.774
Mkt Cap
$171.473M
52W Low
$0.36
52W High
$2.35
52W Position info
115% above low
Off High info
67% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

TNYA has more than doubled off its 52-week low of $0.36.

Summary

Tenaya Therapeutics reported its first-quarter 2026 results, showing a significant improvement in its financial performance with a net loss of $19.3 million, narrower than the $26.9 million loss in the prior-year quarter. Diluted EPS also improved to $(0.09) from $(0.24) year-over-year, while revenue increased to $0.2 million. This financial update follows the company's last 10-K which detailed a $90.6 million net loss for 2025. The company also highlighted strong operational progress, including the completion of enrollment and dosing in Phase 1b/2 cohorts for TN-201 and TN-401, early efficacy signals, and new partnerships, including an $8 million CIRM grant. The narrowing net loss and positive clinical advancements are crucial for a clinical-stage biotech, potentially extending its cash runway and de-risking its pipeline. Investors will be watching for further clinical data readouts and continued progress towards pivotal trials.

At the time of this announcement, TNYA was trading at $0.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $171.5M. The 52-week trading range was $0.36 to $2.35. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

TNYA - Latest Insights

TNYA
Nov 04, 2026, 4:41 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.377
Real-time Price: $0.3305 info
Change: -$0.0465 (-12%) info
Market Cap: $72.025M info
TNYA
Nov 04, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.385
Real-time Price: $0.3305 info
Change: -$0.0545 (-14%) info
Market Cap: $72.025M info
TNYA
Oct 13, 2026, 4:42 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $0.530
Real-time Price: $0.3305 info
Change: -$0.1995 (-38%) info
Market Cap: $72.025M info
TNYA
Sep 14, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.6395
Real-time Price: $0.3305 info
Change: -$0.309 (-48%) info
Market Cap: $72.025M info
TNYA
Aug 05, 2026, 4:46 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $0.7497
Real-time Price: $0.3305 info
Change: -$0.4192 (-56%) info
Market Cap: $72.025M info